Search Results - "Staudacher, Lionel"

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial) by Martinez Chanza, Nieves, Soukane, Louisa, Barthelemy, Philippe, Carnot, Aurélien, Gil, Thierry, Casert, Vinciane, Vanhaudenarde, Vincent, Sautois, Brieuc, Staudacher, Lionel, Van den Brande, Jan, Culine, Stephane, Seront, Emmanuel, Gizzi, Marco, Albisinni, Simone, Tricard, Thibault, Fantoni, Jean Christophe, Paesmans, Marianne, Caparica, Rafael, Roumeguere, Thierry, Awada, Ahmad

“…Cisplatin-based neoadjuvant chemotherapy (NAC) followed by surgery is the standard treatment for patients with non-metastatic muscle invasive bladder cancer…”
Get full text

Avelumab as the basis of neoadjuvant regimen in platinum-eligible and -ineligible patients with nonmetastatic muscle-invasive bladder cancer: AURA (Oncodistinct-004) trial by Martinez Chanza, Nieves, Carnot, Aurelien, Barthélémy, Philippe, Casert, Vinciane, Staudacher, Lionel, Van Den Brande, Jan, Sautois, Brieuc, Vanhaudenarde, Vincent, Seront, Emmanuel, Debien, Veronique, Gil, Thierry, Paesmans, Marianne, Kotecki, Nuria, Ignatiadis, Michail, Albisinni, Simone, Fantoni, Jean Christophe, Tricard, Thibault, Diamond, Romain, Roumeguere, Thierry Andre, Awada, Ahmad

“…4517 Background: Nearly half of the patients (pts) diagnosed with non-metastatic muscle invasive bladder cancer are unfit for cisplatin therapy and no…”
Get full text

Performance of 18FDG-PET in the management of non-metastatic HIV+ anal squamous cell carcinoma (ASCC) by Baba Hamed, Nabil, Deplanque, Gael, Kassis, Raid, Gatineau, Michel, Staudacher, Lionel, Chaiba, Imene, Savinelli, Francesco, Sverdlin, Robert, Maiga, Oumou, Marin, Jean Luc, de Parades, Vincent, Lemarchand, Nicolas, Marty, Olivier, Levoir, Damien, Loriau, Jerome, Zerbib, Eric, Zins, Marc, Boulay, Isabelle, Raymond, Eric

“…Abstract only 541 Background: ASCC remains rare, but the incidence has been increasing over the last decade, especially in patients with HIV infection (HIV+)…”
Get full text